arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2006.15715stat.AP
收藏

验证性试验样本量推导的贝叶斯视角综述

A review of Bayesian perspectives on sample size derivation for confirmatory trials

Kevin Kunzmann, Michael J. Grayling, Kim May Lee, David S. Robertson, Kaspar Rufibach, James M. S. Wason

AI总结:

本文综述了将贝叶斯思想融入频率学派验证性试验样本量推导的混合方法,统一了保证、成功概率和期望功效等关键量的定义,并展示其在临床试验中的应用。

摘要:

样本量推导是任何验证性试验规划阶段的关键要素。样本量通常基于对最大可接受I类错误率和最小期望功效的约束来推导。这里,功效依赖于未知的真实效应量。在实践中,功效通常要么针对最小相关效应量计算,要么针对一个可能的点备择假设计算。前者在最小相关效应接近零假设时可能存在问题,从而需要过大的样本量。后者则值得怀疑,因为它没有考虑关于可能备择效应量的先验不确定性。对频率学派试验的样本量推导采取贝叶斯视角,自然成为一种调和关于备择效应量相对先验合理性的论点与基于效应量相关性的观点的方法。文献中已经提出了许多关于如何在实践中实施这种“混合”方法的建议。然而,诸如保证(assurance)、成功概率(probability of success)或期望功效(expected power)等关键量在文献中常常以微妙不同的方式定义。从传统的、完全频率学派的样本量推导方法出发,我们为最常用的“混合”量推导出一致的定义,并强调它们之间的联系,然后讨论并展示它们在临床试验样本量推导背景下的应用。

英文摘要:

Sample size derivation is a crucial element of the planning phase of any confirmatory trial. A sample size is typically derived based on constraints on the maximal acceptable type I error rate and a minimal desired power. Here, power depends on the unknown true effect size. In practice, power is typically calculated either for the smallest relevant effect size or a likely point alternative. The former might be problematic if the minimal relevant effect is close to the null, thus requiring an excessively large sample size. The latter is dubious since it does not account for the a priori uncertainty about the likely alternative effect size. A Bayesian perspective on the sample size derivation for a frequentist trial naturally emerges as a way of reconciling arguments about the relative a priori plausibility of alternative effect sizes with ideas based on the relevance of effect sizes. Many suggestions as to how such `hybrid' approaches could be implemented in practice have been put forward in the literature. However, key quantities such as assurance, probability of success, or expected power are often defined in subtly different ways in the literature. Starting from the traditional and entirely frequentist approach to sample size derivation, we derive consistent definitions for the most commonly used `hybrid' quantities and highlight connections, before discussing and demonstrating their use in the context of sample size derivation for clinical trials.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑